Primarily, the DREAMS logo serves as an acronym for Diversity, Representation, Equity, and Advocacy MatterS. Within the acronym, the design employs the Entrada brand's gradient encapsulated within a series of shapeshifting 'periods' that vary in both size and vertical position. These elements symbolize the upliftment and enrichment of those in need, ultimately manifesting in a subtle resemblance to a 'sunrise' just beyond the 'S'.  Upon closer examination, a deliberate deviation becomes evident: the first period is positioned outside the text, preceding the 'D'. This deliberate design choice symbolizes the disenfranchised and underrepresented members of the Duchenne muscular dystrophy (DMD) community, whose life experiences are often shaped by the societal inequities that we at Entrada Therapeutics strive to alleviate.  At its core, the DREAMS brand is designed with these individuals in mind, encompassing their unique realities and embracing the essence of their human experience. It stands as a visual pledge of our commitment to uplift and support those marginalized within our community.

Diversity, Representation, Equity & Advocacy MatterS

DREAMS for Duchenne

Entrada DREAMS is a competitive grants program designed to fund efforts within the Duchenne muscular dystrophy community to better identify, understand and reach those who are currently underrepresented and underserved.

DREAMS and Belonging

Entrada is building a company culture where everyone can belong, contribute and grow. In the same way, we are committed to working toward a healthcare system that is equitable, inclusive and diverse. Entrada DREAMS is part of our commitment to support Duchenne-focused non-profit organizations in their efforts to address discrimination and disparity in healthcare and to better serve all people living with Duchenne.

DREAMS and Giving

In 2023, three grants of $25,000 (USD) each will be awarded to U.S. based non-profit organizations with project proposals that embrace diversity, inclusivity, accessibility and the creation or expansion of vital services to achieve greater equality within the Duchenne community.

Deadline: Friday, June 30 (before 11:45 PM EST)

Recipients will be notified in August and publicly announced on
World Duchenne Awareness Day on September 7, 2023

Apply Now

Grant Review Committee

Sean Baumstark

Founder, determinence
Podcast Co-Host,
Two Disabled Dudes

Keisha Greaves

CEO & Founder
Girls Chronically Rock

Hugo Trevino, MEd

Disability Services Specialist
University of Illinois at Chicago

Aravindhan Veerapandiyan, MD

Pediatric Neurologist
Arkansas Children’s Hospital

Eligibility Requirements

  • Must be a U.S. based non-profit organization with services for people living with Duchenne muscular dystrophy

  • Must hold current 501(c)(3) status

Application Requirements

  • Applications must be concise and approximately three (3) pages in length. Font size ≥ 10

  • Statement of target demographic and identified community need(s)

  • A detailed description of the project plan and timeline for implementation

  • A goal that is clearly outlined, measurable, and attainable

  • A project budget detailing how proceeds of the grant will be allocated

  • A commitment to apply grant funding within one-year of receipt and to provide Entrada with a project summary

Only one application per non-profit organization will be considered. A written agreement, defining the basic conditions of the grant, will be entered between Entrada Therapeutics and the award recipients.

Review Criteria

Applications will be judged by an independent review committee comprised of neuromuscular specialists and patient advocates with expertise in Duchenne, Diversity, Equity, Inclusion & Access (DEIA), social impact and health. Each application will be anonymized and reviewed, scored, and ranked using the following criteria:


  • Accessible to intended audience (e.g., multilingual, ADA compliant, culturally relevant, etc.)

  • Informed by minority-led or representative community organization(s)


  • Delivers to underserved community(s) where they are

  • Reproducible in multiple geographies

  • Addresses needs of multiple underserved groups


  • Addresses a clear unmet need

  • Specific objective and measure of success

  • Sustainable


  • Novel idea or program

  • Shows commitment to a new way of working to advance DEIA

In addition to meeting the criteria above, applicants are encouraged to demonstrate collaboration with minority-led or local community organizations to overcome barriers that limit the delivery of health education and support for individuals and families in need.